• español
  • English
  • français
  • Deutsch
  • português (Brasil)
  • italiano
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Parcourir

    Tout UVaDOCCommunautésPar date de publicationAuteursSujetsTitres

    Mon compte

    Ouvrir une session

    Statistiques

    Statistiques d'usage de visualisation

    Compartir

    Voir le document 
    •   Accueil de UVaDOC
    • PUBLICATIONS SCIENTIFIQUES
    • Departamentos
    • Dpto. Cirugía, Oftalmología, Otorrinolaringología y Fisioterapia
    • DEP11 - Artículos de revista
    • Voir le document
    •   Accueil de UVaDOC
    • PUBLICATIONS SCIENTIFIQUES
    • Departamentos
    • Dpto. Cirugía, Oftalmología, Otorrinolaringología y Fisioterapia
    • DEP11 - Artículos de revista
    • Voir le document
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano

    Exportar

    RISMendeleyRefworksZotero
    • edm
    • marc
    • xoai
    • qdc
    • ore
    • ese
    • dim
    • uketd_dc
    • oai_dc
    • etdms
    • rdf
    • mods
    • mets
    • didl
    • premis

    Citas

    Por favor, use este identificador para citar o enlazar este ítem:https://uvadoc.uva.es/handle/10324/68963

    Título
    Modifiable determinants of satisfaction with intravitreal treatment in patients with neovascular age-related macular degeneration
    Autor
    Calles Monar, Paola Stefanía
    Sanabria Ruiz Colmenares, María RosaAutoridad UVA Orcid
    Alonso Tarancón, Ana María
    Coco Martín, Rosa MaríaAutoridad UVA Orcid
    Mayo Iscar, AgustínAutoridad UVA Orcid
    Año del Documento
    2022-05
    Editorial
    Springer Nature
    Descripción
    Producción Científica
    Documento Fuente
    Drugs & Aging, May 2022, vol. 39, n. 5, p. 355-366.
    Résumé
    ABSTRACT. BACKGROUND: The success of intravitreal treatment for neovascular age-related macular degeneration (nAMD) depends on maximal adherence to treatment, which in turn requires patient satisfaction. OBJECTIVE The aim of this study was to assess the factors associated with nAMD patient satisfaction to implement actions to improve treatment experiences and increase adherence. DESIGN This was a prospective, observational, analytical, cross-sectional study. SUBJECTS Our study included 100 consecutive nAMD patients under intravitreal treatment for at least 1 year. METHODS Patients completed the Macular Disease Treatment Satisfaction Questionnaire (MacTSQ) and the EuroQol Visual Analog Scale (EQ VAS). A logistic regression was estimated to model the low values of the satisfaction score (MacTSQ < 50). RESULTS The mean age of patients was 82.1 ± 7.8 years and 62% were female. Males (p = 0.002) and patients who improved their visual acuity (p = 0.004) were more satisfied, while patients who received a higher number of injections (p = 0.036) and treatment in both eyes (p = 0.001) were less satisfied. Higher health-related quality of life was related to higher satisfaction. The sensitivity and specificity of the predictive model were 75.8% and 76.1%, respectively. Factors independently associated with low satisfaction were female sex (odds ratio [OR] 6.84), going to the clinic alone (OR 8.51), longer duration of treatment (OR 0.62), receiving treatment in both eyes (OR 3.54), and suffering a decline in visual acuity (OR 3.30). The questionnaire revealed patients’ needs for more information and injection points closer to their homes. CONCLUSIONS Well-defined areas for improvement were identified, i.e. to improve the information offered to each patient, to incorporate new long-acting drugs, and to establish locations for injection services in peripheral areas.
    Materias Unesco
    3201.09 Oftalmología
    Palabras Clave
    atient Satisfaction, Age-Related Macular Degeneration, Wet Macular Degeneration, Neovascular Age-Related Macular Degeneration, Antivascular Endothelial Growth Factor, Intravitreal Injections.
    ISSN
    1170-229X
    Revisión por pares
    SI
    DOI
    10.1007/s40266-022-00937-y
    Patrocinador
    This research was supported by a grant from Gerencia Regional de Salud de Castilla-León (GRS 2111/A/19). Agustín Mayo-Iscar has been partially supported by the Spanish Ministerio de Economía y Competitividad (grant MTM2017-86061-C2-1-P) and by Consejería de Educación de la Junta de Castilla y León and FEDER (grants VA005P17 and VA002G18)
    Version del Editor
    https://link.springer.com/article/10.1007/s40266-022-00937-y
    Propietario de los Derechos
    Springer
    Idioma
    eng
    URI
    https://uvadoc.uva.es/handle/10324/68963
    Tipo de versión
    info:eu-repo/semantics/submittedVersion
    Derechos
    openAccess
    Aparece en las colecciones
    • Retina - Artículos de Revista [13]
    • IOBA - Artículos de revista [80]
    • DEP11 - Artículos de revista [242]
    Afficher la notice complète
    Fichier(s) constituant ce document
    Nombre:
    18.-Sanabria modifiable determinatnts of satisfaction English edited copia.docx
    Tamaño:
    67.61Ko
    Formato:
    Documento Word
    Voir/Ouvrir
    Attribution-NonCommercial-NoDerivatives 4.0 InternacionalExcepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional

    Universidad de Valladolid

    Powered by MIT's. DSpace software, Version 5.10